PLSM Pulsenmore Ltd. Ordinary Shares
Healthcare$4.49+12.25%ClosedMarket Cap: $29.2M
As of 2026-05-25
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
1.00
P/S
2.10
EV/EBITDA
-5.01
DCF Value
$-1,282.94
FCF Yield
-39.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
84.2%
Operating Margin
-30.4%
Net Margin
-39.6%
ROE
-30.2%
ROA
-15.6%
ROIC
-13.1%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 null | $38.8M | $-9.0M | $— |
| FY null | $40.0M | $-15.9M | $— |
| Q2 null | $1.2M | $-6.8M | $— |
| Q4 null | $1.5M | $-5.7M | $— |
Trading Activity
Insider Trades
View AllSonnenschein Mineluofficer: VP R&D
SellWed Mar 18
Sonnenschein Elazardirector, officer: Chief Executive Officer
SellWed Mar 18
Shmouely Meirofficer: VP Software Development
SellWed Mar 18
Shmouely Meirofficer: VP Software Development
SellWed Mar 18
Loewenstein Anatdirector
SellWed Mar 18
Latest News
Pulsenmore Announces Full Year 2025 Earnings Conference CallPRNewsWire · Wed Mar 25
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
IL
Exchange
—
Beta
0.29
Pulsenmore Ltd. engages in the provision of self-scan ultrasound devices for remote clinical diagnosis and screening in Israel and Europe. The company offers Pulsenmore home ultrasound system, a handheld ultrasound cradle dock with the patient's smartphone; mobile app for uploading images to the cloud for review; and clinician dashboard for clinician to review a stored video or guide a scan in real-time. The company was incorporated in 2014 and is based in Omer, Israel.